SALMO PHARMA AS

8827 DØNNA

Finances

Share Ownership

Return on Equity

84,81 %

Current Ratio

1,86

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	154 924 000	103 286 000	153 618 000	140 106 000
Net Income	23 000 000	23 794 000	28 774 000	24 987 000
Total Assets	58 343 000	86 750 000	97 919 000	127 636 000
Total Equity	27 120 000	4 120 000	326 000	16 552 000

Income (NOK)	2022	2021	2020	2019
Revenue	154 924 000	103 286 000	153 618 000	140 106 000
Expenditure	127 113 000	74 255 000	118 559 000	109 352 000
Operating Profit	27 811 000	29 031 000	35 059 000	30 754 000
Financial Income	335 000	136 000	417 000	147 000
Financial Costs	0	1 000	24 000	114 000
Financial Balance	335 000	135 000	393 000	33 000
Earnings Before Tax	28 147 000	29 166 000	35 453 000	30 787 000
Tax	5 147 000	5 372 000	6 679 000	5 799 000
Net Income	23 000 000	23 794 000	28 774 000	24 987 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	186 000	0	0	0
Total Current Assets	58 158 000	86 750 000	97 919 000	127 636 000
Total Assets	58 343 000	86 750 000	97 919 000	127 636 000
Total Retained Equity	23 965 000	965 000	−2 830 000	396 000
Total Equity	27 120 000	4 120 000	326 000	16 552 000
Total Long-Term Debt	5 000	8 388 000	6 549 000	4 526 000
Total Current Debt	31 218 000	74 242 000	91 045 000	106 558 000
Total Equity and Debt	58 343 000	86 750 000	97 919 000	127 636 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	154 924 000	103 286 000	153 618 000	140 106 000
Other Income	0	0	0	0
Revenue	154 924 000	103 286 000	153 618 000	140 106 000
Cost of Goods Sold	126 612 000	73 795 000	117 457 000	108 890 000
Salary Costs	0	0	0	0
Depreciation	49 000	0	0	0
Impairment	0	0	0	0
Expenditure	127 113 000	74 255 000	118 559 000	109 352 000
Operating Profit	27 811 000	29 031 000	35 059 000	30 754 000
Financial Income	335 000	136 000	417 000	147 000
Financial Costs	0	1 000	24 000	114 000
Financial Balance	335 000	135 000	393 000	33 000
Dividends	0	20 000 000	45 000 000	20 000 000
Net Income	23 000 000	23 794 000	28 774 000	24 987 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	186 000	0	0	0
Total Tangible Assets	186 000	0	0	0
Total Fiancial Fixed Assets	0	0	0	0
Total Fixed Assets	186 000	0	0	0
Stock	0	38 093 000	29 728 000	49 676 000
Total Investments	0	0	0	0
Cash, Bank	13 415 000	25 564 000	44 448 000	38 067 000
Total Current Assets	58 158 000	86 750 000	97 919 000	127 636 000
Total Assets	58 343 000	86 750 000	97 919 000	127 636 000
Total Equity	27 120 000	4 120 000	326 000	16 552 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	5 000	8 388 000	6 549 000	4 526 000
Creditors	6 983 000	8 047 000	4 815 000	22 421 000
Unpaid Taxes	3 961 000	0	0	424 000
Dividends	0	20 000 000	45 000 000	20 000 000
Other Current Debt	6 744 000	42 663 000	52 574 000	63 713 000
Total Current Debt	31 218 000	74 242 000	91 045 000	106 558 000
Total Equity and Debt	58 343 000	86 750 000	97 919 000	127 636 000

Financial indicators	2022	2021	2020	2019
Return on Equity	84,81 %	577,52 %	8 826,38 %	150,96 %
Debt-to-Equity Ratio	0	2,04	20,09	0,27
Operating Profit Margin	17,95 %	28,11 %	22,82 %	21,95 %
Current Ratio	1,86	1,17	1,08	1,2
Quick Ratio	1,86	2,4	1,6	2,24
Equity Ratio	0,46	0,05	0	0,13
Gross Profit Margin	18,27 %	28,55 %	23,54 %	22,28 %